Pulmatrix Inc PULM 深 沪
已收盘 03-27 16:00:00 美东时间
1.36
-0.150
-9.93%
华盛通- 最 高1.4601
- 今 开1.42
- 成交量 14.54万股
- 最 低 1.32
- 昨 收 1.51
- 总市值 496.71万
- 52周最高 9.37
- 市盈率 静 --
- 换手率 3.98%
- 52周最低 1.32
- 委 比 15.76%
- 总股本 365.23万
- 历史最高 4235.00
- 量 比 0.78
- 振 幅 9.28%
- 历史最低 1.32
- 每 手 1
- 风险率 1.78%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pulmatrix Signs Agreement To Acquire Eos SENOLYTIX; Financial Terms Undisclosed
Pulmatrix, Inc. (Nasdaq: PULM) ("Pulmatrix") and Eos SENOLYTIX, Inc. ("Eos"), a biotechnology company developing novel gerotherapeutic peptides targeting mitochondrial dysfunction in aging-related diseases, today jointly
03-26 20:03
Pulmatrix agrees to acquire Eos SENOLYTIX; $19 million financing grows to advance PTC-2105 program
Pulmatrix agrees to acquire Eos SENOLYTIX; $19 million financing grows to advance PTC-2105 program Pulmatrix agreed to acquire Eos SENOLYTIX, with the combined company expected to operate under the Eos SENOLYTIX name. The combined company is expected to trade on Nasdaq under the ticker EOSX after th
03-26 20:03
Pulmatrix shares are trading lower after a planned acquisition was rejected.
Pulmatrix shares are trading lower after a planned acquisition was rejected.
03-03 03:48
BRIEF-Pulmatrix Announces Termination Of Prior Planned Merger And Continues Pursuit Of Alternative Merger Opportunities
BRIEF-Pulmatrix Announces Termination Of Prior Planned Merger And Continues Pursuit Of Alternative Merger Opportunities March 2 (Reuters) - Pulmatrix Inc PULM.O : PULMATRIX ANNOUNCES TERMINATION OF PRIOR PLANNED MERGER AND CONTINUES PURSUIT OF ALTERNATIVE MERGER OPPORTUNITIES PULMATRIX INC - ADVANCE
03-02 21:17
Cullgen Terminates Merger Agreement With Pulmatrix
Cullgen Terminates Merger Agreement With Pulmatrix Pulmatrix said Cullgen Inc. terminated their previously planned merger agreement on Feb. 28, 2026, after delays in obtaining required approval. The company said it is continuing discussions on alternative merger opportunities. Disclaimer: This news
03-02 21:01
Pulmatrix Q4 EPS $(0.25) Up From $(0.55) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.25) per share. This is a 54.55 percent increase over losses of $(0.55) per share from the same period last year.
02-26 21:19
BRIEF-Pulmatrix And Cullgen Continue To Pursue Merger
Dec 18 (Reuters) - Pulmatrix Inc PULM.O: PULMATRIX AND CULLGEN CONTINUE TO PURSUE MERGER WHILE GRANTING EACH OTHER WAIVERS TO EXPLORE ALTERNATIVES PULMATRIX INC - CO AND CULLGEN WAIVE "NO SOLICITATION...
2025-12-18 23:02
Pulmatrix Mulls Divestment Of Clinical Assets, Proprietary iSPERSE Technology As Part Of Proposed Merger With Cullgen
As part of the proposed merger, Pulmatrix currently intends to divest its assets including its proprietary dry powder delivery technology, iSPERSE™, which enables delivery of small- or large-molecule drugs to the
2025-10-16 20:17
Pulmatrix Q3 EPS $(0.24) Up From $(0.71) YoY
Pulmatrix (NASDAQ:PULM) reported quarterly losses of $(0.24) per share. This is a 66.2 percent increase over losses of $(0.71) per share from the same period last year.
2025-10-16 20:14
Pulmatrix GAAP EPS of -$0.24
Pulmatrix press release (NASDAQ:PULM): Q3 GAAP EPS of -$0.24. The Company's total cash and cash equivalents balance as of September 30, 2025, was $4.8 million. The Company anticipates that its cash po...
2025-10-16 20:13
